Promoter shareholding in Ishita Drugs increased slightly YoY (+0.12%) but is stagnant QoQ (+0.01%), indicating limited confidence from insiders.

Institution shareholding remained unchanged both YoY and QoQ, suggesting a lack of interest from institutional investors, which typically signals caution.

Public shareholding saw a YoY increase (+3.14%) but a QoQ decline (-0.23%), reflecting potential volatility and a reactionary stance from retail investors.